Abstract
The sensitivity of 12Pseudomonas aeruginosa strains (5 mucoid and 7 non-mucoid strains) to serum and the interaction of these strains with the complement system was studied. Five strains (4 mucoid and 1 non-mucoid strains) were lysed in 20 % normal serum as measured by the release of rediolabelled material from3H-adenine labelled bacteria. Three of these strains were also lysed in MgEGTA chelated serum. All strains activated complement via the classical pathway, and six strains were able to activate the alternative complement pathway as well. Slime production did not interfere with bacteriolysis and complement consumption.
Similar content being viewed by others
References
Peterson, P. K.: Host defense againstPseudomonas aeruginosa. In: Sabath, L. D. (ed.):Pseudomonas aeruginosa, the organism, diseases, it causes and their treatment. Hans Hubert Publishers, Bern, 1980, p. 103–118.
Bodey, G. P., Buckley, M., Sathe, Y. S., Freireich, E. J.: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 238–340.
Pennington, J. E.: Lipopolysaccharide Pseudomonas vaccine: efficacy against pulmonary infection withPseudomonas aeruginosa. Journal of Infectious Diseases 1979, 140: 73–80.
Tapper, M. L., Armstrong, D.: Bacteremia due toPseudomonas aeruginosa complicating neoplastic diseases: a progress report. Journal of Infectious Diseases 1974. 133: Supplement 14–23.
Valdivieso, M., Gil-Extremera, B., Zormoza, J., Rodriguez, V., Bodey, G. P.: Gram-negative bacillary pneumonia in the compromised host. Medicine 1977, 56: 241–254.
Whitecar, J. P., Luna, M., Bodey, G. P.: Pseudomonas bacteremia in patients with malignant disease. American Journal of the Medical Sciences 1970, 260: 216–223.
Winkelstein, J. A., Drachman, R. H.: Phagocytosis: the normal process and its clinically significant abnormalities. Pediatric Clinics of North America 1974, 21: 551–569.
Young, L. S., Martin, W. J., Meyer, R. D., Wein-stein, R. J., Anderson, E. T.: Gram-negative rod bacteremia: microbiologic immunologic and therapeutic considerations. Annals of Internal Medicine 1977, 86: 456–471.
Zinner, S. H., McCable, W. R.: The effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. Journal of Infectious Diseases 1976, 133: 37–45.
Young, L. S., Armstrong, D.: Human immunity toPseudomonas aeruginosa I. In vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. Journal of Infectious Diseases 1972, 126: 257–276.
Ziegler, E. J., Douglas, H.:Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonal infection in neutropenia. Journal of Infectious Diseases 1979, 139: 288–296.
Sokol, P. A., Ohman, D. E., Iglewski, B. H.: A more sensitive plate assay for detection of protease production ofPseudomonas aeruginosa. Journal of Clinical Microbiology 1979, 9: 538–540.
Habs, I.: Untersuchungen über die O-Antigenie vonPseudomonas aeruginosa. Zeitschrift für Hygiene und Infektionskrankheiten 1957, 144: 218–228.
Forsgren, A., Quie, P. G.: Opsonic activity in human serum chelated with ethylene glycoltetraacetic acid. Immunology 1974, 26: 1251–1256.
Friedlander, A. M.: DNA release as a direct measure of microbial killing. I. Serum bactericidal activity. Journal of Immunology 1975, 115: 1401–1408.
Mayer, M. M.: Complement fixation. In: Kabat, E. A., Mayer, M. M. (ed.): Experimental immunochemistry. Charles C. Thomas, Springfield, 1967, p. 133–149.
Govan, J., Reiss-Levy, E., Bader, L., Schonell, M.:Pseudomonas pneumonia with bacteremia. Medical Journal of Australia 1977, 1: 627–628.
Vosti, K. L., Randall, E.: Sensitivity of serologically classified strains ofEscherichia coli of human origin to the serum bactericidal system. American Journal of the Medical Sciences 1970, 259: 114–119.
Guttman, R. M., Waisbren, B. A.: Bacterial blocking activity of specific IgG in chronicPseudomonas aeruginosa infection. Clinical Experimental Immunology 1975, 19: 121–130.
Schwarzmann, S., Boring, J. R.: Antiphagocytic effect of slime from a mucoid strain ofPseudomonas aeruginosa. Infection and Immunity 1971, 3: 762–767.
Høiby, N., Olling, S.:Pseudomonas aeruginosa infection in cystic fibrosis. Acta Pathologica et Microbiologica Scandinavica (C) 1977, 85: 107–114.
Baltimore, R. S., Mitchell, M.: Immunologic investigations of mucoid strains ofPseudomonas aeruginosa; comparison of susceptibility to opsonic antibody in mucoid and non-mucoid strains. Journal of Infectious Diseases 1975, 141: 238–247.
Peterson, P. K., Kim, Y., Schmeling, S., Lindeman, M., Verhoef, J., Quie, P. G.: Complementmediated phagocytosis ofPseudomonas aeruginosa. Journal of Laboratory and Clinical Medicine 1978, 92: 883–894.
Author information
Authors and Affiliations
Additional information
This paper is part of a D.Sc. thesis to be submitted to the Senate of the Technion Israel Institute of Technology, Haifa, Israel.
Rights and permissions
About this article
Cite this article
Meshulam, T., Verbrugh, H. & Verhoef, J. Serum-induced lysis ofPseudomonas aeruginosa . Eur. J, Clin. Microbiol. 1, 1–6 (1982). https://doi.org/10.1007/BF02014132
Issue Date:
DOI: https://doi.org/10.1007/BF02014132